Tirzepatide: Also known as LY3298176, Tirzepatide is a dual glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptor agonist
Efficacy and safety of once-weekly semaglutide monotherapy versus placebo in patients with type 2 diabetes (SUSTAIN 1): A double-blind, randomised, placebo-controlled, parallel-group, multinational, multicentre phase 3a trial
It is also involved in the production of phospholipids that form healthy cell membranes, the synthesis of creatine for cellular energy, and numerous other metabolic pathways that maintain normal cell function throughout the body
Supplies Important notes Always use new, sterile U-100 insulin syringes (29-31 gauge) and dispose of them in a sharps container
Frequently Asked Questions When should I increase my GLP-1 dose